| Sarah Etkin-sefcik, LCSW | |
|
210 Church St, Saratoga Springs, NY 12866-1010 | |
| (518) 580-0520 | |
| Not Available |
| Full Name | Sarah Etkin-sefcik |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 24 Years |
| Location | 210 Church St, Saratoga Springs, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023553146 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 082474-R (New York) | Primary |
| Entity Name | Pathways Counseling Of Saratoga, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720540776 PECOS PAC ID: 5496097529 Enrollment ID: O20190422000628 |
News Archive
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market the antihistamine Fexofenadine Hydrochloride Tablets, 30 mg, 60 mg, and 180 mg.
Cases of type 2 diabetes continue to rise in the US. And while the development of the disease is more commonly associated with risk factors such as obesity, high blood pressure, and physical inactivity, research has shown that stress can also have a significant impact.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has presented for the first time to the medical community data from its Phase 1B clinical study with its defensin-mimetic antibiotic compound, PMX-30063.
You win some, you lose some. A protein that protects the body from tissue damage also increases the risk of tumors, according to a study conducted at Washington University School of Medicine in St. Louis. Moderate reduction of the protein level protects against tumor formation but increases susceptibility to tissue injury.
For the first time, stem cell researchers at the University of Minnesota have coaxed human embryonic stem cells to create cancer-killing cells in the laboratory, paving the way for future treatments for various types of cancers (or tumors).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Etkin-sefcik, LCSW 222 East Ave, Saratoga Springs, NY 12866-3619 Ph: () - | Sarah Etkin-sefcik, LCSW 210 Church St, Saratoga Springs, NY 12866-1010 Ph: (518) 580-0520 |
News Archive
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received tentative approval from the U.S. Food and Drug Administration to manufacture and market the antihistamine Fexofenadine Hydrochloride Tablets, 30 mg, 60 mg, and 180 mg.
Cases of type 2 diabetes continue to rise in the US. And while the development of the disease is more commonly associated with risk factors such as obesity, high blood pressure, and physical inactivity, research has shown that stress can also have a significant impact.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has presented for the first time to the medical community data from its Phase 1B clinical study with its defensin-mimetic antibiotic compound, PMX-30063.
You win some, you lose some. A protein that protects the body from tissue damage also increases the risk of tumors, according to a study conducted at Washington University School of Medicine in St. Louis. Moderate reduction of the protein level protects against tumor formation but increases susceptibility to tissue injury.
For the first time, stem cell researchers at the University of Minnesota have coaxed human embryonic stem cells to create cancer-killing cells in the laboratory, paving the way for future treatments for various types of cancers (or tumors).
› Verified 5 days ago
Jennifer L Plisko, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 77c Excelsior Ave, Saratoga Springs, NY 12866 Phone: 518-573-7410 | |
Katherine Mary Evanico, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 211 Church St, Saratoga Springs, NY 12866 Phone: 518-580-2865 | |
Ms. Linn Spencer Hayes, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4 Franklin Sq, Saratoga Springs, NY 12866 Phone: 518-583-0963 Fax: 518-583-0369 | |
Ms. Susan Voss Shanley, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 163 Woodlawn Ave, Saratoga Springs, NY 12866 Phone: 518-581-9250 Fax: 518-581-9250 | |
Gina C Villiere, LCSW-R Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 530 Maple Ave, Saratoga Springs, NY 12866 Phone: 518-588-8378 | |
Megan Johnson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 135 S Broadway, Saratoga Springs, NY 12866 Phone: 518-584-9030 |